2022 - Page 2 of 3 - BrainsWay

News & Events

September 20, 2022

BrainsWay CEO Christopher von Jako Named Honorary Chair of NAMIWalks Silicon Valley

BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

September 16, 2022

Cigna extends coverage for Brainsway’s brain stimulation device to treat OCD

Policy change by Cigna to now begin covering Deep TMS for the treatment of obsessive-compulsive disorder,...

September 14, 2022

BrainsWay Announces Private Insurance Coverage from Cigna Corporation for OCD Treatment

Cigna® Issues Favorable Policy for Deep TMS to Address Medication-Resistant Obsessive-Compulsive Disorder BURLINGTON,...

August 31, 2022

BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, August 31, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

August 29, 2022

BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression

Depression Clearance for the Proprietary Deep TMS™ H7 Coil Represents the Company’s 9th FDA Clearance BURLINGTON,...

August 26, 2022

Leaders Say Surveillance Of ‘Quiet Quitters’ Doesn’t Work But 3 Steps Do

Story featuring insights from four CEOs (including BrainsWay’s CEO, Dr. Christopher von Jako) about...

August 22, 2022

Depression ruined her life for years. Kansas City doctor’s ‘helmet’ changed everything.

Patient Lori Jackson details her history of depression, her unsuccessful treatments with medication,...

August 10, 2022

BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 14% Year-over-Year in Q2 2022 Conference call to be held today, August 10, 2022, at...

July 27, 2022

BrainsWay to Report Second Quarter Financial Results on August 10, 2022

BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 28, 2022

BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression

The Company’s Groundbreaking Deep TMS™ Treatment is Included in Israel’s Health Basket of Essential...

June 23, 2022

BrainsWay Donates $10,000 to Mental Health America in Support of Mental Health Awareness Month

BURLINGTON, Mass. and JERUSALEM, Israel, June 23, 2022 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

June 22, 2022

BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference

BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 20, 2022

Mental Health Experts Say Deep TMS Therapy Should Have a Larger Public Health Impact

Deep TMS patient Gabe Hogan details his backstory on living with depression and how he found relief using...

June 21, 2022

BrainsWay Announces Positive OCD Coverage Policy from Blue Cross Blue Shield® (BCBS) Licensee Highmark BCBS for Deep TMS™

Highmark BCBS Covers 6.8 Million Members in Four States BURLINGTON, Mass. and JERUSALEM, June 21, 2022...

May 23, 2022

Rosecrance offers patients effective new mood therapy

News segment centering around local patient Thomas Hartzell’s treatment-resistant depression and...

May 17, 2022

Sun Valley throws open its mental health doors

Live the Sun Valley Experience Mental Health Fair held by Sun Valley Medical Center and Sun Valley Research...

May 11, 2022

BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30...

May 9, 2022

BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales

Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of Experience BURLINGTON,...

Find a provider near you or contact us today.

Find a Provider Contact Us